Tag: shared development infrastructure

Final SDI funding call now open
September 2, 2026

Good news: on Tuesday, September 1, ZonMw opened the final funding round within the PharmaNL Shared Development Infrastructure (SDI) programme line. This programme line focuses on strengthening the infrastructure for the development, scaling up and production of (innovative) medicines in the Netherlands. This call addresses the themes identified in the revised 2026 SDI Investment Agenda […]

bacteriofagen
A New Generation of Infection Control: PharmaNL Project INFECTORY Builds Dutch GMP Infrastructure for Bacteriophages
July 9, 2026

Antimicrobial resistance is a growing global challenge. Physicians are increasingly confronted with infections that no longer respond to existing antibiotics, while the development of new antibiotics continues to lag behind. A newly awarded Shared Development Infrastructure (SDI) project within PharmaNL aims to take an important next step by establishing a Dutch GMP production environment for […]

IgA
IgA as a Gamechanger: PHARMIGA Explores a New Generation of Antibodies
June 9, 2026

In the most recent funding round of the Shared Development Infrastructure (SDI) programme of PharmaNL, the project PHARMIGA has been awarded. The initiative taps into the largely untapped potential of antibodies, key components of the human immune system. Professor of Chemistry and Pharmaceutical Sciences Albert Heck (Utrecht University), an expert in biomolecular mass spectrometry and […]

vier nieuwe projecten
Four New Projects Launch under Shared Development Infrastructure
February 26, 2026

In the coming months, four new projects will get underway as part of the PharmaNL Shared Development Infrastructure (SDI) Call 2025, the second funding round within the PharmaNL SDI program line. The selected projects focus on building and/or upgrading infrastructure for the development, scale-up, and production of innovative medicines in the Netherlands. A total of […]

Nanoworx mijlpalen
Nanoworx Milestones: New Infrastructure and First Commercial Projects
February 11, 2026

How can we better harness the potential of nanomedicine? Nanoworx, one of the projects funded under PharmaNL’s Shared Development Infrastructure program, was established as a new Contract Research Organisation (CRO) to automate and accelerate the development of innovative nanomedicines. With support from PharmaNL and TU/e, Nanoworx is building a sustainable infrastructure to create nanomedicine libraries […]

project ACESO
Impact Series 6: ACESO. Innovation in screening infrastructure
November 27, 2025

The ACESO project is central in this sixth edition of the PharmaNL Impact Series. In this series, we spotlight a different project each time that, with the support of PharmaNL and made possible by ZonMw, contributes to the future of the Dutch pharmaceutical sector. What are the first results, what challenges are there, and what […]

Impact Series 3: Nanoworx. Smart Optimization for Scale-Up Makes the Difference
June 25, 2025

In the PharmaNL Impact Series, we spotlight innovative projects that have taken off thanks to funding from PharmaNL. What are the initial results? What challenges have emerged? And what can others learn from these experiences? In this third episode, we take a closer look at Nanoworx, a promising initiative within the PharmaNL program line Shared […]

iPsomics
Impact Series 2: iPsomics. From Academic Innovation to Personalized Cancer Treatment
June 19, 2025

The PharmaNL Impact Series showcases real-life examples of how PharmaNL projects are progressing. What early results are emerging, what challenges are being faced, and what lessons can others take from them? In this second episode, we caught up with Peter Ketelaar and Floris Foijer of iPsomics, a promising life science start-up born out of the […]

Hubertus Irth
English Translation of Investment Agenda Part 3 Now Available
June 12, 2025

The English translation of PharmaNL Investment Agenda Part 3 is now available. This document, part of the agenda presented on 22 August 2024, focuses on the Shared Development Infrastructure programme line. The Investment Agenda serves as a roadmap for targeted investments aimed at strengthening the Dutch pharmaceutical value chain.

terugblik
From Pitch to Partnership: PharmaNL Connection Days 2025
April 16, 2025

Three rooms filled with engaged professionals, exchange, and ideas shaping the future of the pharmaceutical sector—that was the outcome of the PharmaNL Connection Days in March and April 2025. The central theme was to stimulate project applications for the Shared Development Infrastructure (SDI) subsidy call, which opened on March 18. Floor van de Watering, program […]